Pharma, telecom shine, while IT and oil & gas face pressure. Rural recovery aids FMCG, but urban consumption lags. Banking steady despite NIM squeeze. What's next?
3h
December quarter earnings brought a mixed bag of surprises across sectors. While rural demand revival lifted consumer-driven ...
Wedbush raised the firm’s price target on SpringWorks Therapeutics (SWTX) to $81 from $77 and keeps an Outperform rating on the shares ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback